Introduction
You get a blood test. The results come back, a letter says everything is 'within range', and that is the end of the conversation. This feels reassuring, but it might not tell you the whole story.
Standard laboratory reference ranges are usually based on population data, often representing the central 95% of values from a healthy reference population. This means that approximately 5% of healthy people will fall outside the reference range for any individual test. These ranges help doctors interpret your results, but they don't necessarily tell them what is normal for you.
For many biomarkers, your results may change significantly over time while remaining within the normal range. In some circumstances, these changes can provide valuable clues about your health.
Research following 109 participants over nearly three years identified more than 67 clinically actionable health findings through longitudinal profiling, illustrating how repeated measurements can reveal information that a single test might miss. However, this was an intensive research programme involving multiple types of health data, rather than routine blood testing alone.
So, what can tracking your blood results over time actually tell you, and when does a change matter?
Why your previous blood results matter
A single blood test provides a snapshot of your health at one point in time. Previous results can add another dimension by showing whether a biomarker has remained stable, increased or decreased.
This is known as longitudinal monitoring, and it is already an established part of managing many medical conditions.
For example, a gradual decline in kidney function may be more informative than a single estimated glomerular filtration rate (eGFR) measurement. Similarly, changes in HbA1c over several months can help clinicians assess blood glucose control.
However, not all biomarkers benefit equally from repeated testing. Some fluctuate naturally throughout the day, while others are influenced by recent exercise, illness, food intake or medications.
The value of monitoring therefore depends on which biomarker is being measured, why it is being tested and whether the result could change clinical management.
Discover the 5 habits that boost your longevity
Unlock a doctor-reviewed 5-day guide to the core pillars of long-term health—diet, exercise, lifestyle, sleep, and mental wellbeing. Evidence-based, practical, and designed to help you start making meaningful changes today.
No spam. Unsubscribe anytime.
By continuing, you agree to receive occasional updates from Emerald. See our Privacy Policy.
Which biomarkers are useful to track over time?
There are several commonly measured biomarkers where previous results can provide important clinical information.
Biomarker | What tracking can tell us |
HbA1c | Changes in average blood glucose over approximately 2–3 months, particularly useful in diabetes management |
Cholesterol (LDL and non-HDL) | Response to lifestyle changes or cholesterol-lowering treatment and information relevant to cardiovascular risk |
Creatinine and eGFR | Changes in kidney function, particularly when assessing chronic kidney disease |
Haemoglobin | Changes that may suggest developing or resolving anaemia, interpreted alongside other blood results and symptoms |
HbA1c: understanding changes in blood glucose
HbA1c reflects average blood glucose over approximately the preceding two to three months.
For someone with diabetes, repeated measurements are important for assessing treatment effectiveness and guiding clinical decisions. In people at increased risk of diabetes, repeat testing may also be appropriate depending on their results and overall risk.
However, small fluctuations in HbA1c do not necessarily indicate deteriorating metabolic health. Changes need to be interpreted in the context of measurement variability, conditions affecting red blood cells and established diagnostic thresholds.
Cholesterol: looking beyond a single result
Cholesterol levels are important in assessing cardiovascular risk, but an individual result rarely tells the whole story.
Clinicians consider cholesterol alongside factors such as age, blood pressure, smoking and medical history. Repeat lipid measurements are particularly useful after starting or changing cholesterol-lowering treatment, helping assess whether treatment is having the intended effect.
A rising cholesterol level does not automatically mean someone needs medication. Equally, a result within the laboratory reference range does not necessarily mean cardiovascular risk is low.
Kidney function: when trends are particularly important
Kidney function is one of the clearest examples of why previous results matter.
Creatinine and eGFR are commonly used to assess how well the kidneys are filtering blood. A single eGFR measurement may not establish whether kidney function is stable or declining.
NICE recommends considering previous eGFR measurements when assessing kidney function and using repeat measurements to establish chronicity or investigate a new reduction.
Importantly, changes in kidney function should also be interpreted alongside urine albumin measurements and the wider clinical picture.
Haemoglobin: identifying changes that may suggest anaemia
Haemoglobin is the protein in red blood cells responsible for carrying oxygen around the body.
A reduction in haemoglobin over time may be useful when investigating symptoms such as fatigue, breathlessness or dizziness. Previous results can help doctors determine whether anaemia is new, longstanding or worsening.
However, haemoglobin can also fluctuate for reasons unrelated to disease, and interpreting changes requires consideration of other blood count measurements, medical history and symptoms.
How doctors use your previous blood test results
Previous blood results can provide useful context during a medical consultation, particularly when investigating new symptoms or monitoring an existing condition.
Your doctor can compare previous measurements, consider whether a change is clinically meaningful and decide whether further testing or treatment is appropriate.
If you have access to previous blood test results, these can be useful to share with your healthcare professional, particularly if tests were performed by different providers. However, you shouldn't need to analyse the results yourself or determine which changes are significant.
It is also important to recognise that more testing isn't always better. Repeated blood tests without a clear clinical reason can identify harmless fluctuations, leading to unnecessary investigations and anxiety.
The aim is not to measure everything as frequently as possible, but to use the right tests at the right time to make informed decisions about your health.
Longevity starts with awareness
Less than £1/day. Test 115+ biomarkers. Personalised plan and 1:1 GP support.
Conclusion
A single blood test tells your doctor whether you resemble most other people. A trend tells them whether you resemble yourself.
Looking at blood results over time can reveal information that a single measurement may miss. For some biomarkers, particularly those used to monitor diabetes, cardiovascular risk and kidney function, previous measurements are already an important part of clinical care.
However, not every change is meaningful, and tracking more biomarkers doesn't necessarily translate into better health outcomes.
The real value of longitudinal blood testing lies in combining previous results with clinical expertise to build a more complete picture of your health.
Related articles
Test 124 biomarkers for fine-tuning your health
See your results in 3 days with high-level accuracy and a certified GP-reviewed action plan